FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Objections, Support for FDA Drug Regulatory Modernization

Public Citizen and PhRMA air their disagreement over an FDA proposal to use integrated review documents in communications about new drug approvals.

Medical Devices

FDA Clears 4Web Interbody Fusion Device

FDA clears a 4Web Medical 510(k) to market its Cervical Spine Truss System-Stand Alone interbody fusion device.

Human Drugs

Support for Heart Failure Endpoints Guidance

Five stakeholders offer supporting comments on an FDA draft guidance on endpoints for developing drugs to treat heart failure.

Federal Register

Comments Reopened on Dronabinol Scheduling

Federal Register notice: FDA reopens the comment period for a 3/1 notice on international drug scheduling for Dronabinol.

Medical Devices

Biobeat Patch/Watch for Monitoring Vitals Cleared

FDA clears a Biobeat 510(k) for its patch and watch for measuring blood pressure, oxygenation and heart rate in hospitals, clinics, long-term care and...

Human Drugs

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes CTX Lifesciences and Ningbo Pulisi Daily Chemical Products.

FDA General

SCOTUS Narrows Agency Deference: Attorney

Attorney Anne Walsh says regulated companies may cite a recent Supreme Court decision when challenging the notion of judicial deference to FDAs interp...

Federal Register

Guide on Drugs for Treating Male Breast Cancer

Federal Register notice: FDA makes available a draft guidance entitled Male Breast Cancer: Developing Drugs for Treatment.

Human Drugs

Inspection Looked at AveXis Manipulated Assay Data

A recently posted Establishment Inspection Report involving AveXis Zlogensma, which is behind a data manipulation investigation, shows an extensive re...

Human Drugs

FDA Antimicrobial Drug Head Joins Regeneron

CDER Office of Antimicrobial Products director Edward Cox leaves FDA to join Regeneron as regulatory affairs vice president.